Apotex Successfully Invalidates Patent on Nexium
AstraZeneca has been selling Nexium in Canada for 13 years. It is prescribed to treat ulcers, gastroesophageal reflux disease (GERD) and related diseases. The active
July 17, 2014
2 Comments